Allergy Therapeutics Financial Overview
Allergy Therapeutics's market cap is currently £706.27M. The company's EPS TTM is p-0.006; its P/E ratio is -14.05; Allergy Therapeutics is scheduled to report earnings on December 11, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
